BioCardia

BCDA61

Penny Stock

$3.08arrow_drop_up10.39%$0.29

Penny Stock

BCDA61

$3.08

arrow_drop_up10.39%$0.29

Penny Stock

Performance History

Key Stats
Open	$2.86
Prev. Close	$2.82
EPS	-5.33
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$10.40M
PE Ratio	-

	LOW	HIGH
Day Range	2.80	2.98
52 Week Range	0.32	5.70

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-5.33

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About BioCardia (BCDA)

BioCardia Inc (BCDA) is a medical technology company that specializes in the development of innovative therapies for cardiovascular diseases. The company focuses on the development of regenerative biologic therapies to treat heart failure and other cardiovascular conditions. With a mission to improve the lives of patients suffering from heart disease, BioCardia is committed to advancing the field of cardiology through cutting-edge research and innovation.

As of the latest market session, BioCardia Inc has a stock price of $2.45. Over the years, the stock has shown volatility, but has also demonstrated potential for growth. Investors interested in the company should consider its stock price history to gain insights into its performance and potential future trends. The stock has experienced fluctuations in line with market conditions and industry dynamics, making it an interesting option for those looking for exposure to the healthcare sector.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Peter A. Altman Ph.D.
Headquarters: Sunnyvale
Employees: 30
Exchange: NASDAQ

Keep an eye on BioCardia

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is BioCardia 's (BCDA) price per share?

The current price per share for BioCardia (BCDA) is $3.08. The stock has seen a price change of $0.29 recently, indicating a 10.39% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for BioCardia (BCDA)?

For BioCardia (BCDA), the 52-week high is $5.7, which is 85.06% from the current price. The 52-week low is $0.32, the current price is 862.5% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is BioCardia (BCDA) a growth stock?

BioCardia (BCDA) has shown an average price growth of 0.41% over the past three years. It has received a score of 12 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying BioCardia as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is BioCardia (BCDA) stock price performance year to date (YTD)?

As of the latest data, BioCardia (BCDA) has a year-to-date price change of -69%. Over the past month, the stock has experienced a price change of -23%. Over the last three months, the change has been -7.78%. Over the past six months, the figure is -46.85%. Looking at a longer horizon, the five-year price change stands at -96.74%.

help

Is BioCardia (BCDA) a profitable company?

BioCardia (BCDA) has a net income of -$11.57M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 13.84% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -54.97K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $66K. Operating income is noted at -$11.64M. Furthermore, the EBITDA is -$8.53M.

help

What is the market capitalization of BioCardia (BCDA)?

BioCardia (BCDA) has a market capitalization of $9.77M. The average daily trading volume is 287.51K, indicating the stock's liquidity and investor engagement.

News

PERSONALIZED MEDICINE

8/21/2024

FDA Approves CardiAMP® Heart Failure II Protocol Amendment to Use Proprietary Cell Population Analysis Screening to Define Treatment

BioCardia Announces United States Patent Issuance on Intramyocardial Delivery of Cell Aggregates to the Heart Including Minimally Invasive Radial Artery Approach

PATENTS

6/7/2024

BioCardia Announces United States Patent Issuance on Intramyocardial Delivery of Cell Aggregates to the Heart Including Minimally Invasive Radial Artery Approach